When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Celgene CVR down 20% on potential delay in key approval
Bristol-Myers Squibb Company
The Contingent Value Right (CVR) (NYSE:BMY.RT) associated with Bristol Myers Squibb's (BMY-2.2%)$74B takeover of Celgene is down ~24% today in apparent reaction to management comments at a Citigroup conference revealing that the manufacturing plant for CAR T therapies has not yet been inspected by the FDA.
More news on: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, bluebird bio, Inc., Healthcare stocks news, Stocks on the move,